Back to Search
Start Over
Short communication: Glucagon-like peptide-2 and coccidiosis alter tight junction gene expression in the gastrointestinal tract of dairy calves.
- Source :
-
Journal of dairy science [J Dairy Sci] 2015 May; Vol. 98 (5), pp. 3432-7. Date of Electronic Publication: 2015 Feb 26. - Publication Year :
- 2015
-
Abstract
- Tight junction (TJ) proteins are integral factors involved in gut barrier function, and therapy with glucagon-like peptide-2 (GLP-2) enhances gut integrity. Our aim was to assess effects of GLP-2 treatment on mRNA expression of 8 TJ complex proteins in the intestine of dairy calves not infected or infected with Eimeria bovis at 11±3d of age. Mucosal epithelium from jejunum, ileum, and cecum was collected at slaughter from Holstein bull calves assigned to 4 groups: noninfected, buffer-treated (n=5); noninfected, GLP-2 treated (n=4); E. bovis-infected, buffer-treated (n=5); and E. bovis-infected, GLP-2-treated (n=4). Infected calves were orally dosed with 100,000 to 200,000 sporulated E. bovis oocysts on d 0; GLP-2-treated calves received 50 µg of GLP-2/kg of body weight subcutaneously twice daily for 10d beginning on d 18; and buffer-treated calves received an equal injection volume of 0.01 M Na bicarbonate buffer. All calves were killed on d 28. The mRNA expression of coxsackie and adenovirus receptor (CXADR), claudins 1, 2, and 4 (CLDN1, CLDN2, and CLDN4), F11 receptor (F11R), junction adhesion molecule 2 (JAM2), occludin (OCLN), and tight junction protein ZO-1 (TJP1) was determined by real-time quantitative PCR. In jejunum and ileum, an interaction of E. bovis infection and GLP-2 treatment on gene expression was noted. In jejunum of noninfected calves, GLP-2 increased CXADR, CLDN2, OCLN, and TJP1 mRNA expression but had no effect on mRNA expression in infected calves. Treatment with GLP-2 also increased tight junction protein ZO-1 protein expression in jejunum of noninfected calves as determined by immunohistochemistry. In ileum, E. bovis decreased expression of JAM2, OCLN, and TJP1 in buffer-treated calves, and GLP-2 increased TJP1 expression in infected calves. In cecum, E. bovis infection reduced expression of CXADR, CLDN4, F11R, and OCLN, and GLP-2 therapy increased expression of CLDN4, F11R, OCLN, and TJP1. Results are consistent with studies in nonruminants showing decreased expression of TJ complex proteins in the intestinal tract during pathogen-induced diarrhea and increased TJ protein expression in intestinal tissues in response to GLP-2 treatment. In conclusion, E. bovis reduces gene expression of TJ proteins primarily in cecum of calves 28d postinfection, and GLP-2 increases expression of selected TJ genes in intestinal tissues. Use of GLP-2 to improve gut barrier function in ruminants during pathogen-induced diarrhea warrants additional study.<br /> (Copyright © 2015 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Animals, Newborn
Cattle
Cattle Diseases drug therapy
Cattle Diseases parasitology
Claudin-1 genetics
Claudin-1 metabolism
Claudin-2 genetics
Claudin-2 metabolism
Claudin-4 genetics
Claudin-4 metabolism
Coccidiosis veterinary
Coxsackie and Adenovirus Receptor-Like Membrane Protein genetics
Coxsackie and Adenovirus Receptor-Like Membrane Protein metabolism
Eimeria drug effects
Eimeria isolation & purification
Gastrointestinal Tract drug effects
Intestinal Mucosa metabolism
Junctional Adhesion Molecule A genetics
Junctional Adhesion Molecule A metabolism
Occludin genetics
Occludin metabolism
RNA, Messenger genetics
RNA, Messenger metabolism
Zonula Occludens-1 Protein metabolism
Coccidiosis drug therapy
Gastrointestinal Tract parasitology
Gene Expression
Glucagon-Like Peptide 2 pharmacology
Zonula Occludens-1 Protein genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1525-3198
- Volume :
- 98
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of dairy science
- Publication Type :
- Academic Journal
- Accession number :
- 25726101
- Full Text :
- https://doi.org/10.3168/jds.2014-8919